Open AccessA prospective randomized trial comparing accelerated concurrent chemoradiotherapy with conventional concurrent chemoradiotherapy in locally advanced carcinoma cervix (IIA–IVA)
Author(s) -
Poorva Vias,
Harpreet Angural,
Rajeev Kumar Seam,
Manoj Kumar Gupta,
Manish Gupta,
Vikas Fotedar,
Anup Negi
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_626_19
Subject(s) - medicine , brachytherapy , cervix , chemoradiotherapy , concomitant , cervical cancer , radiation therapy , cisplatin , randomized controlled trial , surgery , carcinoma , cancer , chemotherapy
Cervical cancer ranks fourth in women worldwide. The management requires a multidisciplinary approach. Concomitant chemoradiotherapy with cisplatin, followed by brachytherapy, is the standard approach. Accelerated radiotherapy (ART) can be used to decrease the treatment duration which can further lead to better outcomes.